Skip to main content
. 2020 Apr 7;26(4):2191–2199. doi: 10.1007/s12253-020-00801-7

Fig. 1.

Fig. 1

Comparison of HPV16 VL according to p53 staining patterns in the treatment-naive (a) and the recurrent (b) group